Iodinated contrast agents in patients with myasthenia gravis: a retrospective cohort study

Currently, it has not been satisfactorily established, whether modern low-osmolality iodinated contrast agents (ICAs) used in computed tomography (CT) studies are a risk factor for exacerbation of myasthenic symptoms. The rate of acute adverse events as well as delayed clinical worsening up to 30 da...

Descripción completa

Detalles Bibliográficos
Autores principales: Rath, Jakob, Mauritz, Matthias, Zulehner, Gudrun, Hilger, Eva, Cetin, Hakan, Kasprian, Gregor, Auff, Eduard, Zimprich, Fritz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486553/
https://www.ncbi.nlm.nih.gov/pubmed/28550477
http://dx.doi.org/10.1007/s00415-017-8518-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486553/
https://www.ncbi.nlm.nih.gov/pubmed/28550477
http://dx.doi.org/10.1007/s00415-017-8518-8

Ejemplares similares